LIVE
New today 1,203
Updated 593
New executives 2,734
Reported capital $ 0
Sign up Log in

BIOPHARMA ORAL, CORP.

CORPORATION (JOINT-STOCK COMPANY) SUSPENDED No ranking1,010,412 total
RUC: 155695232-2-2020
Total views
30
Avg / month
3
Year peak
5
Current month +100.0 % vs Nov
4

Company information

Folio
155695232 Mercantil
Registration date
27/07/2020
Validity
PERPETUAL
Status
SUSPENDED
Last update
23/10/2025 (hace 1 mes)
Request update

Highlights BIOPHARMA ORAL, CORP.

Currency
NO-PAR VALUE SHARES
Share capital
0.00
RUC
155695232-2-2020

Executives BIOPHARMA ORAL, CORP. (7)

Name
Role
Links
View
  • Name SE OTORGA PODER GENERAL A FAVOR DEL SEÑOR RAÚL ALBERTO MORALES RUBIO Attorney-in-Fact 1
    Role: Attorney-in-Fact
    Links: 1
  • Name RAÚL ALBERTO MORALES RUBIO Director / President 3
    Role: Director / President
    Links: 3
  • Name TOMÁS FLORES CHERIGO Director / Secretary 1
    Role: Director / Secretary
    Links: 1
  • Name JENNY DEL CARMEN NIETO FUENTES Director / Treasurer 5
    Role: Director / Treasurer
    Links: 5
  • Name GGH & CO., S.A. Subscriber 911
    Role: Subscriber
    Links: 911
  • Name LEC & CIA., S.A. Subscriber 740
    Role: Subscriber
    Links: 740
  • Name SALVO QUE LA JUNTA DIRECTIVA DISPONGA OTRA COSA, EL PRESIDENTE OSTENTARÁ LA REPRESENTACIÓN LEGAL DE LA SOCIEDAD. EN AUSENCIA DE ÉSTE LA OSTENTARÁ, EN SU ORDEN, EL VICEPRESIDENTE, EL TESORERO O EL SECRETARIO. REPRESENTATIVE - —
    Role: REPRESENTATIVE
    Links: -
    —
*Links: number of companies where the executive appears with a role or relation.

Documents BIOPHARMA ORAL, CORP. (4)

Act
Date
View
  • Act Electronic Entry Nº 4 (ANNOTATION OF SUSPENSION FOR FEE DELINQUENCY) Entry 229572/2025 (0) 29/06/2025
    Date: 29/06/2025
  • Act Electronic Entry Nº 3 (ANNOTATION OF SUSPENSION POR FALTA DE AGENTE RESIDENTE 90 DÍAS) Entry 92678/2024 (0) 06/03/2024
    Date: 06/03/2024
  • Act Electronic Entry Nº 2 (Resident Agent Resignation) Entry 484758/2023 (0) 06/12/2023
    Date: 06/12/2023
  • Act Electronic Entry Nº 1 (Opening of Electronic Folio) Entry 166857/2020 (0) 27/07/2020
    Date: 27/07/2020

Entries / Precedence BIOPHARMA ORAL, CORP. (4)

Procedure / Document type
Year
View
  • Procedure / Doc. Suspensión por Morosidad de Single Fee Ordenada por la DGI 2025
    Year: 2025
  • Procedure / Doc. Correction Due to Registry-Attributed Causes 2024
    Year: 2024
  • Procedure / Doc. Resident Agent Resignation 2023
    Year: 2023
  • Procedure / Doc. Incorporation of Company Capital, Single Fee, Qualification Rights 2020
    Year: 2020
Request deletion
About BIOPHARMA ORAL, CORP.: Summary of BIOPHARMA ORAL, CORP.: entity CORPORATION (JOINT-STOCK COMPANY), status SUSPENDIDO. Address in Township Ciudad, District Panamá, Province Panamá. Registered since 27/07/2020. Estimated traffic: 30 total visits (peak 5). Position: no ranking available. See representatives, branches, documents and filings.